CNTB Connect Biopharma Holdings Limi
$2.04▼ -0.97%
Healthcare
Other
After hours
$2.03▼ -0.42%
Sep 11, 7:58 PM ET
Volume 862.7K
Avg Volume (10D) 1.51M
Key Metrics & Fundamentals
Market Cap
$128.47M
P/E Ratio
–
Div Yield
–%
52W Range
1.23 - 3.82
% vs 50 MA
-8.82%
% vs 200 MA
-16.26%
RSI-14
45.6
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.30
Free Cash Flow
-$15.92M
Gross Rev
$2.77M
Gross Profit
$2.77M
EBITDA
-$17.44M
COGS
–
Operating Exp
$20.37M
Operating Income
-$17.60M
EBIT
-$17.60M
Pretax Income
-$17.22M
Net Income
-$17.28M
EPS (Diluted)
-0.27
Price & Volume History
Loading chart…
Recent News
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 8:05 PM
Top Premarket Gainers
MT Newswires · Aug 31, 2026 11:16 AM
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 12, 2026 8:05 PM
Oppenheimer Initiates Connect Biopharma at Outperform With $8 Price Target
MT Newswires · Jul 9, 2026 12:30 PM
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
GlobeNewswire · Jun 17, 2026 1:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CNTB's money flow as a full page
Social Sentiment
No Reddit posts found for CNTB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.